Susquehanna International Group, LLP Voyager Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $8,077 - $12,978	-1,400 Reduced 3.94%	34,100 $199,000
Q2 2024 Aug 15, 2024	BUY	$7.42 - $10.54 $81,620 - $115,939	11,000 Added 44.9%	35,500 $280,000
Q1 2024 May 07, 2024	SELL	$7.15 - $10.84 $102,245 - $155,012	-14,300 Reduced 36.86%	24,500 $228,000
Q4 2023 Feb 14, 2024	BUY	$6.28 - $8.81 $4,396 - $6,167	700 Added 1.84%	38,800 $327,000
Q3 2023 Nov 14, 2023	SELL	$7.55 - $11.25 $138,165 - $205,875	-18,300 Reduced 32.45%	38,100 $295,000
Q2 2023 Aug 11, 2023	SELL	$6.94 - $13.99 $238,736 - $481,256	-34,400 Reduced 37.89%	56,400 $645,000
Q1 2023 May 16, 2023	BUY	$6.0 - $10.78 $151,800 - $272,734	25,300 Added 38.63%	90,800 $700,000
Q4 2022 Feb 14, 2023	SELL	$4.94 - $6.61 $604,162 - $808,403	-122,300 Reduced 65.12%	65,500 $399,000
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $40,661 - $54,531	7,300 Added 4.04%	187,800 $1.11 Million
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $479,108 - $1 Million	-99,400 Reduced 35.51%	180,500 $1.07 Million
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $273,625 - $939,280	99,500 Added 55.16%	279,900 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $291,460 - $654,900	118,000 Added 189.1%	180,400 $489,000
Q2 2021 Aug 11, 2021	BUY	$3.94 - $5.44 $183,210 - $252,960	46,500 Added 292.45%	62,400 $258,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $1,001 - $1,375	-100 Reduced 0.63%	15,900 $170,000
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $124,775 - $220,255	-15,500 Reduced 49.21%	16,000 $202,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $274,348 - $360,590	-21,400 Reduced 40.45%	31,500 $439,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $750,259 - $1.3 Million	-46,000 Reduced 46.51%	52,900 $910,000
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $682,808 - $992,528	35,600 Added 56.24%	98,900 $2.69 Million
Q1 2019 May 15, 2019	BUY	$8.0 - $19.66 $307,200 - $754,944	38,400 Added 154.22%	63,300 $1.21 Million
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $70,438 - $148,010	8,200 Added 49.1%	24,900 $234,000
Q3 2018 Nov 14, 2018	SELL	$17.11 - $21.74 $592,006 - $752,204	-34,600 Reduced 67.45%	16,700 $316,000
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $254,752 - $363,584	15,200 Added 42.11%	51,300 $1 Million
Q1 2018 May 15, 2018	SELL	$16.16 - $31.31 $544,592 - $1.06 Million	-33,700 Reduced 48.28%	36,100 $678,000
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $397,224 - $838,512	-32,400 Reduced 31.7%	69,800 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $855,413 - $2.1 Million	102,200	102,200 $2.1 Million

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.1 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$29.4 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.2 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account